Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes

Published on Feb 1, 2017in Value in Health5.037
· DOI :10.1016/j.jval.2016.11.019
Rob Baltussen40
Estimated H-index: 40
(Radboud University Nijmegen),
Maarten Jansen5
Estimated H-index: 5
(Radboud University Nijmegen)
+ 5 AuthorsG.J. van der Wilt32
Estimated H-index: 32
(Radboud University Nijmegen)
Abstract Priority setting in health care has been long recognized as an intrinsically complex and value-laden process. Yet, health technology assessment agencies (HTAs) presently employ value assessment frameworks that are ill fitted to capture the range and diversity of stakeholder values and thereby risk compromising the legitimacy of their recommendations. We propose "evidence-informed deliberative processes" as an alternative framework with the aim to enhance this legitimacy. This framework integrates two increasingly popular and complementary frameworks for priority setting: multicriteria decision analysis and accountability for reasonableness. Evidence-informed deliberative processes are, on one hand, based on early, continued stakeholder deliberation to learn about the importance of relevant social values. On the other hand, they are based on rational decision-making through evidence-informed evaluation of the identified values. The framework has important implications for how HTA agencies should ideally organize their processes. First, HTA agencies should take the responsibility of organizing stakeholder involvement. Second, agencies are advised to integrate their assessment and appraisal phases, allowing for the timely collection of evidence on values that are considered relevant. Third, HTA agencies should subject their decision-making criteria to public scrutiny. Fourth, agencies are advised to use a checklist of potentially relevant criteria and to provide argumentation for how each criterion affected the recommendation. Fifth, HTA agencies must publish their argumentation and install options for appeal. The framework should not be considered a blueprint for HTA agencies but rather an aspirational goal—agencies can take incremental steps toward achieving this goal.
  • References (49)
  • Citations (28)
📖 Papers frequently viewed together
174 Citations
11 Authors (Kevin Marsh, ..., Nancy Devlin)
117 Citations
30 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Louise Brereton (University of Sheffield)H-Index: 12
#2Christine Ingleton (University of Sheffield)H-Index: 21
Last. Wija Oortwijn (Ecorys)H-Index: 11
view all 15 authors...
Background:Stakeholders are people with an interest in a topic. Internationally, stakeholder involvement in palliative care research and health technology assessment requires development. Stakeholder involvement adds value throughout research (from prioritising topics to disseminating findings). Philosophies and understandings about the best ways to involve stakeholders in research differ internationally. Stakeholder involvement took place in seven countries (England, Germany, Italy, Lithuania, ...
12 CitationsSource
#1David J. Hunter (Durham University)H-Index: 31
#2Katharina Kieslich ('KCL': King's College London)H-Index: 7
Last. Iestyn Williams (University of Birmingham)H-Index: 15
view all 7 authors...
Purpose – The purpose of this paper is to reflect on the findings of this special issue and discusses the future challenges for policy, research and society. The findings suggest that challenges emerge as a result of legitimacy deficits of both consensus and contestatory modes of public involvement in health priority setting. Design/methodology/approach – The paper draws on the discussions and findings presented in this special issue. It seeks to bring the country experiences and case studies to...
12 CitationsSource
#1Bill Jenkins (Edin.: University of Edinburgh)H-Index: 3
This paper sheds new light on the prevalence of evolutionary ideas in Scotland in the early nineteenth century and establish what connections existed between the espousal of evolutionary theories and adherence to the directional history of the earth proposed by Abraham Gottlob Werner and his Scottish disciples. A possible connection between Wernerian geology and theories of the transmutation of species in Edinburgh in the period when Charles Darwin was a medical student in the city was suggested...
7 CitationsSource
#1Pablo Alonso-Coello (Cochrane Collaboration)H-Index: 50
#2Holger J. Schünemann (McMaster University)H-Index: 109
Last. Andrew D Oxman (FHI: Norwegian Institute of Public Health)H-Index: 93
view all 13 authors...
#### Summary points Healthcare decision making is complex. Decision-making processes and the factors (criteria) that decision makers should consider vary for different types of decisions, including clinical recommendations, coverage decisions, and health system or public health recommendations or decisions.1 2 3 4 However, some criteria are relevant for all of these decisions, including the anticipated effects of the options being considered, the certainty of the evidence for those effects (also...
172 CitationsSource
#1Sripen Tantivess (Health Intervention and Technology Assessment Program)H-Index: 18
Abstract—Thailand achieves universal health coverage through the introduction of three benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these schemes includes all medicines referenced in the National List of Essential Medicines. However, the CSMBS pays for nonessential drugs (NEDs) for particular conditions. The CSMBS's cost escalation prompted the Ministry of Finance to tightly control drug e...
4 CitationsSource
Zusammenfassung Die Offentlichkeit sollte bei der Entscheidungsfindung im Gesundheitswesen beteiligt werden, insbesondere dann, wenn Entscheidungstrager in Politik und Selbstverwaltung vor der schwierigen Aufgabe der Prioritatensetzung stehen. Es gibt einen allgemeinen Konsens uber die Notwendigkeit fur eine starkere Patientenzentrierung, insbesondere in HTA-Prozessen. Im internationalen Vergleich werden dazu verschiedene Moglichkeiten der Beteiligung der Offentlichkeit (Burger, Versicherte und ...
3 CitationsSource
#1Praveen Thokala (University of Sheffield)H-Index: 16
#2Nancy DevlinH-Index: 41
Last. Maarten Joost IJzerman (UT: University of Twente)H-Index: 40
view all 11 authors...
Health care decisions are complex and involve confronting trade-offs between multiple, often conflicting, objectives. Using structured, explicit approaches to decisions involving multiple criteria can improve the quality of decision making and a set of techniques, known under the collective heading multiple criteria decision analysis (MCDA), are useful for this purpose. MCDA methods are widely used in other sectors, and recently there has been an increase in health care applications. In 2014, IS...
174 CitationsSource
#1Norman Daniels (Harvard University)H-Index: 44
#2G.J. van der Wilt (Radboud University Nijmegen)H-Index: 32
Healthcare technology assessment (HTA) aims to support decisions as to which technologies should be used in which situations to optimize value. Because such decisions will create winners and losers, they are bound to be controversial. HTA, then, faces a dilemma: should it stay away from such controversies, remaining a source of incomplete advice and risking an important kind of marginalization, or should it enter the controversy? The question is a challenging one, because we lack agreement on pr...
13 CitationsSource
#1Norman Daniels (Harvard University)H-Index: 44
#2Thalia Porteny (Harvard University)H-Index: 3
Last. Julian Urritia (Harvard University)H-Index: 1
view all 3 authors...
All societies face the need to make judgments about what interventions (both public health and personal medical) to provide to their populations under reasonable resource constraints. Their decisions should be informed by good evidence and arguments from health technology assessment (HTA). But if HTA restricts itself to evaluations of safety, efficacy, and cost-effectiveness, it risks being viewed as insufficient to guide health decision-makers; if it addresses other issues, such as budget impac...
32 CitationsSource
#1Philip Wahlster (FAU: University of Erlangen-Nuremberg)H-Index: 11
#2Mireille Goetghebeur (Analytica)H-Index: 4
Last. Peter Kotanko (FAU: University of Erlangen-Nuremberg)H-Index: 39
view all 5 authors...
Background The diffusion of health technologies from translational research to reimbursement depends on several factors included the results of health economic analysis. Recent research identified several flaws in health economic concepts. Additionally, the heterogeneous viewpoints of participating stakeholders are rarely systematically addressed in current decision-making. Multi-criteria Decision Analysis (MCDA) provides an opportunity to tackle these issues. The objective of this study was to ...
28 CitationsSource
Cited By28
#1Olivia Biermann (KI: Karolinska Institutet)H-Index: 2
#2Salla AtkinsH-Index: 9
Last. Kerri VineyH-Index: 11
view all 5 authors...
Objective To explore experts’ views on factors influencing national and global active case-finding (ACF) policy development and implementation, and the use of evidence in these processes. Design This is an exploratory study based on semistructured expert interviews. Framework analysis was applied. Participants The study involved a purposive sample of 39 experts from international, non-governmental and non-profit organisations, funders, government institutions, international societies, think tank...
#1Christine Leopold (Harvard University)H-Index: 11
#2Christine Y. Lu (Harvard University)H-Index: 19
Last. Anita K. Wagner (Harvard University)H-Index: 31
view all 3 authors...
BACKGROUND: Public health care payer organizations face increasing pressures to make transparent and sustainable coverage decisions about ever more expensive prescription drugs, suggesting a need for public engagement in coverage decisions. However, little is known about countries' approaches to integrating public preferences in existing funding decisions. The aim of this study was to describe how Belgium and New Zealand used deliberative processes to engage the public and to identify lessons le...
#1Alexander Moreno-Calderón (National University of Colombia)
#2Thai S. Tong (University of Sheffield)
Last. Praveen Thokala (University of Sheffield)H-Index: 16
view all 3 authors...
Objective The objectives of this systematic review were to identify studies using Multi-Criteria Decision Analysis (MCDA) software tools to support health prioritisation processes and describe the technical capabilities of the MCDA software tools identified.
#1Aris Angelis (LSE: London School of Economics and Political Science)H-Index: 11
#2M. Linch (UCLH: University College Hospital)
Last. Panos Kanavos (LSE: London School of Economics and Political Science)H-Index: 3
view all 9 authors...
Abstract Multiple Criteria Decision Analysis (MCDA) has emerged as a likely methodology for Health Technology Assessment (HTA). However limited empirical evidence is available on its use by decision-makers and only as part of single-setting exercises, without cross-county studies available. This pilot study applies the Advance Value Framework (AVF), an MCDA methodology for HTA based on multi-attribute value theory, through a series of case studies with decision-makers in four countries, to explo...
#1Gustaf OrtsäterH-Index: 1
#2Fredrik Borgström (KI: Karolinska Institutet)H-Index: 29
view all 4 authors...
Background RESPIMAT® re-usable enables patients to re-use the inhaler and its availability therefore reduces the number of inhalers and associated wastage.
#1Gustaf OrtsäterH-Index: 1
#2Fredrik Borgström (KI: Karolinska Institutet)H-Index: 29
view all 4 authors...
Introduction The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies and inclusion of ecological considerations in the decision-making process for purchasing and funding of healthcare technologies. The objective of this study was to perform budget impact analysis of adop...
Objectives Proceeding from a basic concept underpinning economic evaluation, opportunity cost, this study aims to explain how different approaches to economics diverge quite dramatically in their ideas of what constitutes appropriate valuation, both in principle and practice. Because the concept of opportunity cost does not inherently specify how valuation should be undertaken or specify how appropriate any economic value framework (EVF) might be, the three main economics-based approaches to pro...
1 CitationsSource
#1Hillegonda Maria Dutilh Novaes (USP: University of São Paulo)H-Index: 21
#2Patrícia Coelho de Soárez (USP: University of São Paulo)H-Index: 13
O texto se propoe a compreender as doencas raras e drogas orfas no contexto das politicas de incorporacao de tecnologias nos sistemas de saude e suas repercussoes sobre a teoria e pratica da Avaliacao de Tecnologias em Saude. Entre as doencas raras foram privilegiadas aquelas decorrentes de alteracoes geneticas, por se constituirem em casos paradigmaticos para a compreensao do que representam para a medicina, a partir dos anos 1970, as mudancas que ocorrem nas formas de diagnosticar, classificar...
Abstract Technological innovation creates new treatment opportunities, while also putting healthcare budgets under strain. To deal with the rising costs of hospital medicines, the regional governments in Denmark have developed a new model for prioritising the adoption and use of hospital medicine. Marking a shift from previous policies, the new model formalises the evaluation of clinical benefit, adds an assessment of treatment costs and ensures a relatively high degree of direct stakeholder inv...